Allegro Diagnostics to Present at 2012 Biotechnology Industry Organization (BIO) International Convention

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics today announced its participation in the BIO Business Forum at the BIO International Convention, being held June 18-20 in Boston. Michael D. Webb, President and CEO, will present on Wednesday, June 20 at 2:15 p.m. EDT in room 104C of the Boston Convention and Exhibition Center. Mr. Webb will provide an overview of Allegro’s molecular testing platform for the early detection of lung cancer, as well as its lead genomic test, BrochoGen™.